Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Prestige Brands Holdings Inc Acquires Care Pharmaceuticals


Tuesday, 9 Jul 2013 08:07am EDT 

Prestige Brands Holdings Inc announced its acquisition of Care Pharmaceuticals Pty Ltd. (Care) of Bondi Junction, New South Wales, Australia, a privately-held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults. The acquisition is effective July 1, 2013. Prestige funded the acquisition with a combination of its existing credit facility and cash on the balance sheet. Financial terms of the acquisition have not been disclosed. Sawaya Segalas, Inc. LLC acted as exclusive financial advisor to Prestige Brands on this transaction.